Whitehawk Therapeutics appoints Vijay Iyengar to board
Whitehawk Therapeutics said Vijay Iyengar was appointed as a Class III director, effective September 9, 2026. The item cites an original SEC filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
Whitehawk Therapeutics appoints Vijay Iyengar to board of directors
Whitehawk Therapeutics appoints Vijay Iyengar, MD, to board
Whitehawk Therapeutics appoints Vijay Iyengar to its board
Whitehawk Therapeutics, Inc. says it has appointed Vijay Iyengar, MD, to its board of directors.